IMVT Stock-Based Compensation
Immunovant Inc · Stock-Based Compensation
IMVT Stock-Based Compensation
Latest reported$50.99Mperiod ending
IMVT Stock-Based Comp ($1.81M → $50.99M)
Annual stock-based compensation
High-resolution chart · PNG
IMVT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 55,724,000 | |
| 49,487,000 | |
| 41,116,000 | |
| 32,296,000 | |
| 34,244,000 | |
| 0 | |
| 6,963,000 | |
| 1,308,000 | |
| 1,812,488 |